
Torsemide Injection
Form: Injection
Strength: 10 mg/mL.
Reference Brands: Demadex(US & EU)
Category: Heart Disorder
Torsemide injection, marketed as Demadex, is approved in the US by the FDA and in the EU via EMA for edema and heart failure management requiring rapid diuresis. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market entry strategies, visit PharmaTradz. Ensuring regional compliance is critical for timely approval, safe use, and global availability, supporting effective management of fluid overload and cardiovascular health worldwide.
Quick Response Guaranteed | Verified Suppliers
Back to ListingThe Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Aliskiren Tablets
Strength: 150 mg, 300 mg
Form: Tablets
Reference Brands: Tekturna(US & EU)
View DetailsAtenolol Tablets
Strength: 25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Tenormin(US)
View DetailsMetoprolol Tartrate Tablet
Strength: IR: 25 mg, 50 mg, 100 mg; ER: 25 mg, 50 mg, 100 mg, 200 mg
Form: Tablets(IR & ER)
Reference Brands: US: Lopressor(IR); Toprol-XL(ER)
View DetailsNifedipine Tablets(Ir/Er)
Strength: 10 mg, 20 mg, 30 mg, 60 mg, 90 mg (IR and ER forms)
Form: Tablet(IR & ER)
Reference Brands: Procardia(US);
View DetailsQuick Response Guaranteed | Verified Suppliers